Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.

Tucci M, Stucci S, Savonarola A, Ciavarella S, Cafforio P, Dammacco F, Silvestris F.

Br J Haematol. 2013 Jun;161(6):821-31. doi: 10.1111/bjh.12333. Epub 2013 Apr 18.

PMID:
23594390
[PubMed - indexed for MEDLINE]
2.

Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro.

Tucci M, Ciavarella S, Strippoli S, Brunetti O, Dammacco F, Silvestris F.

Exp Hematol. 2011 Jul;39(7):773-83.e1. doi: 10.1016/j.exphem.2011.04.006. Epub 2011 Apr 25.

PMID:
21569821
[PubMed - indexed for MEDLINE]
3.

IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage.

Gupta N, Barhanpurkar AP, Tomar GB, Srivastava RK, Kour S, Pote ST, Mishra GC, Wani MR.

J Immunol. 2010 Aug 15;185(4):2261-72. doi: 10.4049/jimmunol.1000015. Epub 2010 Jul 19.

PMID:
20644169
[PubMed - indexed for MEDLINE]
Free Article
4.

Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.

Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaissé JM.

Cancer Res. 2005 Nov 1;65(21):9943-52.

PMID:
16267019
[PubMed - indexed for MEDLINE]
Free Article
5.

IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.

Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F, Suzuki N, Yonehara Y, Maeno M.

Biochimie. 2010 Apr;92(4):398-404. doi: 10.1016/j.biochi.2009.12.011. Epub 2010 Jan 4.

PMID:
20045440
[PubMed - indexed for MEDLINE]
6.

Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy.

Josselin N, Libouban H, Dib M, Ifrah N, Legrand E, Baslé MF, Audran M, Chappard D.

Pathol Oncol Res. 2009 Mar;15(1):65-72. doi: 10.1007/s12253-008-9092-2. Epub 2008 Aug 28.

PMID:
18752046
[PubMed - indexed for MEDLINE]
7.

Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?

Tucci M, Stucci S, Strippoli S, Dammacco F, Silvestris F.

Oncologist. 2011;16(7):1040-8. doi: 10.1634/theoncologist.2010-0327. Epub 2011 Jun 9. Review.

PMID:
21659611
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Osteoclast function in Paget's disease and multiple myeloma.

Roodman GD.

Bone. 1995 Aug;17(2 Suppl):57S-61S. Review.

PMID:
8579899
[PubMed - indexed for MEDLINE]
9.

The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.

Giuliani N, Colla S, Morandi F, Rizzoli V.

Haematologica. 2004 Sep;89(9):1118-23.

PMID:
15377473
[PubMed - indexed for MEDLINE]
Free Article
11.

Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.

Giuliani N, Ferretti M, Bolzoni M, Storti P, Lazzaretti M, Dalla Palma B, Bonomini S, Martella E, Agnelli L, Neri A, Ceccarelli F, Palumbo C.

Leukemia. 2012 Jun;26(6):1391-401. doi: 10.1038/leu.2011.381. Epub 2012 Jan 6.

PMID:
22289923
[PubMed - indexed for MEDLINE]
12.

Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T.

Blood. 2000 Sep 1;96(5):1953-60.

PMID:
10961900
[PubMed - indexed for MEDLINE]
Free Article
13.

Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.

Kupisiewicz K.

Dan Med Bull. 2011 May;58(5):B4277. Review.

PMID:
21535989
[PubMed - indexed for MEDLINE]
Free Article
14.

Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells.

Alnaeeli M, Penninger JM, Teng YT.

J Immunol. 2006 Sep 1;177(5):3314-26.

PMID:
16920972
[PubMed - indexed for MEDLINE]
Free Article
15.

Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.

Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.

Bone. 2007 Oct;41(4):592-602. Epub 2007 Jun 13.

PMID:
17627913
[PubMed - indexed for MEDLINE]
16.

Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.

Yu X, Huang Y, Collin-Osdoby P, Osdoby P.

J Bone Miner Res. 2003 Aug;18(8):1404-18.

PMID:
12929930
[PubMed - indexed for MEDLINE]
17.

[Role of bone marrow microenvironment in regulation of AP-1 gene expression in multiple myeloma cells].

Chen LJ, Xu JR, Zhou WH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Feb;18(1):103-6. Chinese.

PMID:
20137127
[PubMed - indexed for MEDLINE]
18.

Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.

Zhang F, Tanaka H, Kawato T, Kitami S, Nakai K, Motohashi M, Suzuki N, Wang CL, Ochiai K, Isokawa K, Maeno M.

Biochimie. 2011 Feb;93(2):296-305. doi: 10.1016/j.biochi.2010.10.001. Epub 2010 Oct 14.

PMID:
20937352
[PubMed - indexed for MEDLINE]
19.

CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.

Giuliani N, Lisignoli G, Colla S, Lazzaretti M, Storti P, Mancini C, Bonomini S, Manferdini C, Codeluppi K, Facchini A, Rizzoli V.

Cancer Res. 2008 Aug 15;68(16):6840-50. doi: 10.1158/0008-5472.CAN-08-0402.

PMID:
18703490
[PubMed - indexed for MEDLINE]
Free Article
20.

CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.

Yu X, Huang Y, Collin-Osdoby P, Osdoby P.

J Bone Miner Res. 2004 Dec;19(12):2065-77. Epub 2004 Sep 20.

PMID:
15537451
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk